Literature DB >> 7824425

The use of capsaicin cream in a case of erythromelalgia.

K A Muhiddin1, I W Gallen, S Harries, V R Pearce.   

Abstract

We present a case of erythromelalgia in a 68 year old lady who responded, within 48 hours, to a twice daily topical application of capsaicin cream 0.025%. Capsaicin cream was stopped after 2 months, and 6 months later the patient continued to have the symptomatic relief she experienced initially.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824425      PMCID: PMC2397831          DOI: 10.1136/pgmj.70.829.841

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  ERYTHROMELALGIA.

Authors:  B N CATCHPOLE
Journal:  Lancet       Date:  1964-04-25       Impact factor: 79.321

2.  ERYTHERMALGIA. REVIEW OF 51 CASES.

Authors:  R R BABB; D ALARCON-SEGOVIA; J F FAIRBAIRN
Journal:  Circulation       Date:  1964-01       Impact factor: 29.690

3.  Substance p: localization in the central nervous system and in some primary sensory neurons.

Authors:  T Hökfelt; J O Kellerth; G Nilsson; B Pernow
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

Review 4.  Peptidergic neurones.

Authors:  T Hökfelt; O Johansson; A Ljungdahl; J M Lundberg; M Schultzberg
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

5.  Treatment of erythromelalgia with propranolol.

Authors:  J L Bada
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

6.  Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1992-02       Impact factor: 19.112

7.  Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.

Authors:  J J Michiels; J Abels; J Steketee; H H van Vliet; V D Vuzevski
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

Review 8.  Erythromelalgia: review of clinical characteristics and pathophysiology.

Authors:  R Kurzrock; P R Cohen
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965

9.  Primary erythromelalgia: the role of skin sympathetic nerve activity.

Authors:  Y Sugiyama; S Hakusui; A Takahashi; S Iwase; T Mano
Journal:  Jpn J Med       Date:  1991 Nov-Dec

10.  Erythermalgia with vasculitis: a review.

Authors:  J L Ratz; S F Bergfeld; W D Steck
Journal:  J Am Acad Dermatol       Date:  1979-11       Impact factor: 11.527

View more
  5 in total

1.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

2.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

3.  Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide.

Authors:  R R Wenzel; S Zbinden; G Noll; B Meier; T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 4.  Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.

Authors:  C Rains; H M Bryson
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

Review 5.  Current pain management strategies for patients with erythromelalgia: a critical review.

Authors:  See Wan Tham; Marian Giles
Journal:  J Pain Res       Date:  2018-08-30       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.